Funding Opportunities
Funding Opportunities

Since 1981, AFAR has provided more than $178 million to more than 4,100 talented investigators and students. To learn more about each grant, click below or contact the AFAR grant program staff at

Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty

(Formerly called the AFAR Research Grants for Junior Faculty)

The Glenn Foundation for Medical Research and AFAR provide up to $100,000 for a one- to two-year award to junior faculty (M.D.s and Ph.D.s) to conduct research that will serve as the basis for longer term research efforts on the biology of aging. These investigators study a broad range of biomedical and clinical topics related to aging. Since 1981, over 700 Research Grants for Junior Faculty have been awarded. Please note: The 2019 awards are closed and Letters of Intent are no longer being accepted. Please check back in Fall of 2019 for updated materials.



The Program

The major goal of this program is to assist in the development of the careers of junior investigators committed to pursuing careers in the field of aging research. GMRF and AFAR support research projects concerned with understanding the basic mechanisms of aging rather than disease-specific research. Projects investigating age-related diseases are supported if approached from the point of view of how basic aging processes may lead to these outcomes. Projects concerning mechanisms underlying common geriatric functional disorders are also encouraged, as long as these include connections to fundamental problems in the biology of aging. Projects that deal strictly with clinical problems such as the diagnosis and treatment of disease, health outcomes, or the social context of aging are not eligible.

Examples of potentially fundable areas of research include, but are not limited to:

  • Aging and immune function
  • Stem cell aging
  • Inflammation
  • Genetic control of longevity
  • Neurobiology and neuropathology of aging
  • Invertebrate or vertebrate animal models
  • Cardiovascular aging
  • Aging and cellular stress response
  • Metabolic and endocrine changes

Projects investigating mechanisms of, or putative therapies for, Alzheimer’s Disease and related dementias, are not eligible for this award and should consider applying instead to the Small Research Grant Program for the Next Generation of Researchers in Alzheimer's Disease (R03).

It is anticipated that approximately 10 grants of up to $100,000 each will be awarded in 2019. Applicants may propose to use the award over the course of one or two years as justified by the proposed research. Up to 8% of funds may be budgeted for overhead or indirect costs (not to exceed $7,407). Funding will begin July 1, 2019.


The applicant must be an independent investigator with independent research space as described in a form completed by the Dean or Department Chair, and must be no more than 10 years beyond start of postdoctoral research training as of July 1, 2019. Exceptions to the ten year rule may be requested by emailing an NIH-style biosketch to AFAR at at least one week prior to the deadline date.

The AFAR and Glenn Foundation for Medical Research Grants for Junior Faculty do not provide support for:

  • Postdoctoral fellows in the laboratory of a senior investigator
  • Investigators who have received major extramural funding for research in any area (such as an NIH R01 or NSF Research or equivalent grant) prior to and including the start date of this award (applicants may hold K or R21 funding)
  • Senior faculty, i.e. at the rank of Associate Professor level or higher
  • Former AFAR Research Grant for Junior Faculty recipients
  • Federal employees
  • Applicants for the 2019 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) award
  • Applicants who are conducting research at a for-profit institution, or at an institution outside of the United States
  • Alzheimer's Disease and/or related dementias research

Application Guidelines

Four criteria are used to determine the merit of an application:

  • Qualifications and research record of the applicant;
  • Quality of the proposed research in the basic biology of aging;
  • Excellence of the research environment;
  • Likelihood that the project will advance the applicant's career in aging research.

If you are using animals in your research, please review Principles of Animal Use for Gerontological Research.

Application Procedures

The deadline for receipt of all Letters of Intent is December 17, 2018 at 5:00 p.m. EST. Please refer to the LOI instructions. Incomplete applications cannot be considered.  All Letters of Intent and Institutional Commitment forms must be submitted via email to The Letters of Intent will be reviewed by a committee. Applicants will be notified by late-February, and a subset of applicants will be invited to submit a full application by early April.

Click here for our Frequently Asked Questions page.

Investigators who are invited to submit a full application must have it endorsed by their institution. Awards are announced by mid-June. The award start date is July 1, 2019. AFAR will not provide reviewer critiques to any applicants at any review level.

Reporting Requirements

Final narrative and financial reports are required within three months following the end date of the award. Guidelines for submitting reports as well as other administrative questions can be found here.

Annual Meeting

The award recipients are expected to attend the AFAR Grantee Conference which convenes AFAR grant recipients, mentors and leaders in the field to review and disseminate the research progress of the grantees and their findings. The meeting encourages networking, facilitates collaborations, and enhances the development of leadership.

The major funder is The Glenn Foundation for Medical Research

Founded by Paul F. Glenn in 1965, the mission of the Glenn Foundation for Medical Research is to extend the healthy years of life through research on mechanisms of biology that govern normal human aging and its related physiological decline, with the objective of translating research into interventions that will extend healthspan with lifespan.

Other major funders include:

The AFAR Board of Directors
Proceeds from AFAR's 2017 Luncheon and 2018 Dinner
The James A. and Dorothy R. Brunn Foundation 
David W. Gore
The Hearst Foundation
Diana Jacobs Kalman
The William G. and Helen C. Hoffman Foundation
Diane Nixon
The Irving S. Wright Endowment